Decompensation of cardiovascular disease in infection SARS-CoV-2
- Authors: Melnikova L.V.1, Lokhina T.V.2, Berenshtein N.V.2
-
Affiliations:
- Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
- Penza Institute for Further Training of Physicians - branch of the Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
- Issue: Vol 7, No 4 (2021)
- Pages: 90-94
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288210
- DOI: https://doi.org/10.18565/therapy.2021.4.90-94
- ID: 288210
Cite item
Abstract
Full Text
About the authors
Lyudmila V. Melnikova
Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
Email: lumel2408@yandex.ru
MD, associate professor, professor of the Department of general medical practice and polyclinic therapy 125445, Moscow, 53 Smol'naya Str
Tatiana V. Lokhina
Penza Institute for Further Training of Physicians - branch of the Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
Email: ltv-13ra@mail.ru
MD, head of the Department of therapy, cardiology, functional diagnostics and rheumatology 440060, Penza, 8А Stasova Str
Natalia V. Berenshtein
Penza Institute for Further Training of Physicians - branch of the Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
Email: berenshtein2011@yandex.ru
PhD, associate professor of the Department of ultrasound diagnostics 440060, Penza, 8А Stasova Str
References
- Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5.
- Guzik T.J., Mohiddin S.A., Dimarco A. et al. COVID-19 and the cardiovascular system implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020; 116(10):1666-87. doi: 10.1093/cvr/cvaa106.
- Xiong T.Y., Redwood S., Prendergast B. et al. Coronaviruses and the cardiovascular system: acute and longterm implications. Eur Heart J. 2020; 0: 1-3. doi: 10/1093/eurheartj/ehaa231.
- Kochi A.N., Tagliari A.P., Forleo G.B. et al. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovascuc Electrophysiol. 2020; 31(5): 1003-08. doi.org/10.1111/jce.14479.
- Walls A.C., Park Y.J., Tortorici M.A. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020; 181(2): 281-92.e6. doi: 10.1016/j.cell.2020.02.058.
- Коган Е.А., Березовский Ю.С., Проценко Д.Д. с соавт. Патологическая анатомия инфекции, вызванной SARS-CoV-2. Судебная медицина. 2020; 2: 8-30. doi: https://dx.doi.org/10.19048/2411-8729-2020-6-2-8-30.
- Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020; 14(3): 247-50. doi: 10.1016/j.dsx.2020.03.013.
- Рекомендации ESC по диагностике и лечению острой легочной эмболии, разработанные в сотрудничестве с Европейским респираторным обществом (ERS), 2019. Российский кардиологический журнал. 2020; 8: 3848. doi: https://doi.org/10.15829/1560-4071-2020-3848.
- Bikdeli B., Madhavan M.V., Jimenez D. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75(23): 2950-73. doi: 10.1016/j.jacc.2020.04.031.
- Lew T.W., Kwek T.K., Tai D. et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003; 290(3): 374-80. doi: 10.1001/jama.290.3.374.
- Chong P.Y., Chui P., Ling A.E. et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med. 2004; 128(2): 195-204. doi: 10.1043/1543-2165.
- Анаев Э.Х., Княжеская Н.П. Коагулопатия при covid-19: фокус на антикоагулянтную терапию. Практическая пульмонология. 2020; 1: 3-13.
- Lippi G., Favaloro E.J. D-dimer is associated with severity of coronavirus disease 2019: A pooled analysis. Thromb Haemost. 2020; 120(5): 876-78. doi: 10.1055/s-0040-1709650.
- Lippi G., Plebani M., Henry B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A metaanalysis. Clin Chim Acta. 2020; 506:145-48. doi: 10.1016/j.cca.2020.03.022.
- Tang N., Li D., Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-47. doi: 10.1111/jth.14768.
- Thachil J., Tang N., Gando S. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(5): 1023-26. doi: 10.1111/jth.14810.
- Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-69. doi: 10.1001/jama.2020.1585.
- Буланов А.Ю., Симарова И.Б., Буланова Е.Л. с соавт. Новая коронавирусная инфекция COVID-19: клиническая и прогностическая значимость оценки фибриногена плазмы. Вестник интенсивной терапии им. А.И. Салтанова. 2020; 4: 42-47. doi: https://doi.org/10.21320/1818-474X-2020-4-42-47.